Related references
Note: Only part of the references are listed.Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation
Benjamin Sztrymf et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension
Joy D. Cogan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice
Karl-Otto Larsen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1
Yabing Chen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Dominant negative mutation of the TGF-β receptor blocks hypoxia-induced pulmonary vascular remodeling
YF Chen et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Attenuation of bleomycin-induced pulmonary fibrosis by follistatin
F Aoki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Elevated levels of activin A in heart failure -: Potential role in myocardial remodeling
A Yndestad et al.
CIRCULATION (2004)
The endothelin system in pulmonary arterial hypertension
N Galié et al.
CARDIOVASCULAR RESEARCH (2004)
Soluble CD40 ligand in pulmonary arterial hypertension -: Possible pathogenic role of the interaction between platelets and endothelial cells
JK Damås et al.
CIRCULATION (2004)
Impaired transforming growth factor-β signaling in idiopathic pulmonary arterial hypertension
A Richter et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Potential anti-inflammatory role of activin A in acute coronary syndromes
C Smith et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Cellular and molecular pathobiology of pulmonary arterial hypertension
M Humbert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Clinical classification of pulmonary hypertension
G Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis
H Amthor et al.
DEVELOPMENTAL BIOLOGY (2004)
Mechanisms of disease: Pulmonary arterial hypertension
HW Farber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Activation of hepatocyte growth factor/activin A/follistatin system during hemodialysis: Role of heparin
J Borawski et al.
KIDNEY INTERNATIONAL (2003)
Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure
A Yndestad et al.
CARDIOVASCULAR RESEARCH (2003)
Regulation of activin A expression in mast cells and asthma: Its effect on the proliferation of human airway smooth muscle cells
SH Cho et al.
JOURNAL OF IMMUNOLOGY (2003)
Regulation of cell proliferation, apoptosis, and carcinogenesis by activin
YG Chen et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2002)
Plasminogen activator inhibitor type I increases neointima formation in balloon-injured rat carotid arteries
MB DeYoung et al.
CIRCULATION (2001)
Activin signal transduction pathways
SA Pangas et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2000)
Mechanisms of disease:: Role of transforming growth factor β in human disease.
GC Blobe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
